When the concentrations of ACPA are used for comparison, levels of anti-cyclic citrullinated peptide antibodies (CCP2) have been shown to be higher in sera of COPD patients than controls in one study (35), which was not confirmed by three other groups (28, 33, 34). This evidence concerns the gene PRTN3 and chronic obstructive pulmonary disease.